Skyline Vet Pharma
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $5M
Investors
- 10
About Skyline Vet Pharma
, also known as SVP, operates as a pharmaceutical company. The company was founded by its CEO, Serge Martinod, and George Murphy. In April 2017, Skyline Vet Pharma, Inc. Skyline Vet Pharma conducts research and creates pharmaceuticals for the animal health market. SVP uses novel delivery technologies to reformulate drugs that are used in the animal health industry. The company’s platform uses veterinarian-written prescriptions used by customers to purchase medications.
Who invested in Skyline Vet Pharma
10 investors across 1 round
See all investors in Skyline Vet Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 13, 2017
Amount
$5M
Investors
Questions about Skyline Vet Pharma
Who invested in Skyline Vet Pharma?
Skyline Vet Pharma has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Skyline Vet Pharma raised?
Skyline Vet Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Skyline Vet Pharma last raise money?
Skyline Vet Pharma's most recent round on record is a Series A, in Apr 2017.
What does Skyline Vet Pharma do?
, also known as SVP, operates as a pharmaceutical company.
Where is Skyline Vet Pharma headquartered?
Skyline Vet Pharma is headquartered in US.
Which VCs invest in companies like Skyline Vet Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Skyline Vet Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Skyline Vet Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.